This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giese, A. Articles by Westphal, M. Search for Related Content PubMed PubMed Citation Articles by Giese, A. Articles by Westphal, M.

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

A. Giese, R. Bjerkvig, M.E. Berens, M. Westphal

From the Department of Neurosurgery, University Hospital Lübeck, Lübeck; Department of Neurosurgery, University Hospital Hamburg, Hamburg, Germany; Department of Anatomy and Cell Biology, University of Bergen, Bergen, Norway; and Barrow Neurological Institute, St Joseph’s Hospital, Phoenix, AZ.

Address reprint requests to Alf Giese, MD, Department of Neurosurgery, University Hospital Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany; email: alf.giese{at}neurochirurgie.mu-luebeck.de.

Tumors of glial origin consist of a core mass and a penumbra of invasive, single cells, decreasing in numbers towards the periphery and still detectable several centimeters away from the core lesion. Several decades ago, the diffuse nature of malignant gliomas was recognized by neurosurgeons when super-radical resections using hemispherectomies failed to eradicate these tumors. Local invasiveness eventually leads to regrowth of a recurrent tumor predominantly adjacent to the resection cavity, which is not significantly altered by radiation or chemotherapy. This raises the question of whether invasive glioma cells activate cellular programs that render these cells resistant to conventional treatments. Clinical and experimental data demonstrate that glioma invasion is determined by several independent mechanisms that facilitate the spread of these tumors along different anatomic and molecular structures. A common denominator of this cellular behavior may be cell motility. Gene-expression profiling showed upregulation of genes related to motility, and functional studies demonstrated that cell motility contributes to the invasive phenotype of malignant gliomas. There is accumulating evidence that invasive glioma cells show a decreased proliferation rate and a relative resistance to apoptosis, which may contribute to chemotherapy and radiation resistance. Interestingly, interference with cell motility by different strategies results in increased susceptibility to apoptosis, indicating that this dynamic relationship can potentially be exploited as an anti-invasive treatment paradigm. In this review, we discuss mechanisms of glioma invasion, characteristics of the invasive cell, and consequences of this cellular phenotype for surgical resection, oncologic treatments, and future perspectives for anti-invasive strategies.

Supported by grants Gi 218/2-2 Gi 218/2-4 from the Deutsche Forschungsgemeinschaft.

This article has been cited by other articles:

				H.-D. Kim, T. W. Guo, A. P. Wu, A. Wells, F. B. Gertler, and D. A. Lauffenburger Epidermal Growth Factor-induced Enhancement of Glioblastoma Cell Migration in 3D Arises from an Intrinsic Increase in Speed But an Extrinsic Matrix- and Proteolysis-dependent Increase in Persistence Mol. Biol. Cell, October 1, 2008; 19(10): 4249 - 4259. [Abstract] [Full Text] [PDF]

				A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, et al. Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence Neurology, March 4, 2008; 70(10): 779 - 787. [Abstract] [Full Text] [PDF]

				G. D. King, A.K.M. G. Muhammad, J. F. Curtin, C. Barcia, M. Puntel, C. Liu, S. B. Honig, M. Candolfi, S. Mondkar, P. R. Lowenstein, et al. Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model Neuro-oncol, February 1, 2008; 10(1): 19 - 31. [Abstract] [Full Text] [PDF]

				J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski Interleukin-13 Receptor {alpha}2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy Clin. Cancer Res., January 1, 2008; 14(1): 199 - 208. [Abstract] [Full Text] [PDF]

				G. Gdynia, K. Grund, A. Eckert, B. C. Bock, B. Funke, S. Macher-Goeppinger, S. Sieber, C. Herold-Mende, B. Wiestler, O. D. Wiestler, et al. Basal Caspase Activity Promotes Migration and Invasiveness in Glioblastoma Cells Mol. Cancer Res., December 1, 2007; 5(12): 1232 - 1240. [Abstract] [Full Text] [PDF]

				I. T. Makagiansar, S. Williams, T. Mustelin, and W. B. Stallcup Differential phosphorylation of NG2 proteoglycan by ERK and PKC{alpha} helps balance cell proliferation and migration J. Cell Biol., October 3, 2007; 178(1): 155 - 165. [Abstract] [Full Text] [PDF]

				A. B. Hjelmeland, K. P. Lattimore, B. E. Fee, Q. Shi, S. Wickman, S. T. Keir, M. D. Hjelmeland, D. Batt, D. D. Bigner, H. S. Friedman, et al. The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion Mol. Cancer Ther., September 1, 2007; 6(9): 2449 - 2457. [Abstract] [Full Text] [PDF]

				M. J. Jarzynka, B. Hu, K.-M. Hui, I. Bar-Joseph, W. Gu, T. Hirose, L. B. Haney, K. S. Ravichandran, R. Nishikawa, and S.-Y. Cheng ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion Cancer Res., August 1, 2007; 67(15): 7203 - 7211. [Abstract] [Full Text] [PDF]

				C. Gao, K. Furge, J. Koeman, K. Dykema, Y. Su, M. L. Cutler, A. Werts, P. Haak, and G. F. Vande Woude Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations PNAS, May 22, 2007; 104(21): 8995 - 9000. [Abstract] [Full Text] [PDF]

				M. Desmurget, F. Bonnetblanc, and H. Duffau Contrasting acute and slow-growing lesions: a new door to brain plasticity Brain, April 1, 2007; 130(4): 898 - 914. [Abstract] [Full Text] [PDF]

				T. Demuth, L. B. Reavie, J. L. Rennert, M. Nakada, S. Nakada, D. B. Hoelzinger, C. E. Beaudry, A. N. Henrichs, E. M. Anderson, and M. E. Berens MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival Mol. Cancer Ther., April 1, 2007; 6(4): 1212 - 1222. [Abstract] [Full Text] [PDF]

				A. M. Stein, T. Demuth, D. Mobley, M. Berens, and L. M. Sander A Mathematical Model of Glioblastoma Tumor Spheroid Invasion in a Three-Dimensional In Vitro Experiment Biophys. J., January 1, 2007; 92(1): 356 - 365. [Abstract] [Full Text] [PDF]

				L. Goldberg and Y. Kloog A Ras Inhibitor Tilts the Balance between Rac and Rho and Blocks Phosphatidylinositol 3-Kinase-Dependent Glioblastoma Cell Migration Cancer Res., December 15, 2006; 66(24): 11709 - 11717. [Abstract] [Full Text] [PDF]

				M. Inglese, S. Brown, G. Johnson, M. Law, E. Knopp, and O. Gonen Whole-Brain N-Acetylaspartate Spectroscopy and Diffusion Tensor Imaging in Patients with Newly Diagnosed Gliomas: A Preliminary Study AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2137 - 2140. [Abstract] [Full Text] [PDF]

				X. Lun, D. L. Senger, T. Alain, A. Oprea, K. Parato, D. Stojdl, B. Lichty, A. Power, R. N. Johnston, M. Hamilton, et al. Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV{Delta}M51) on Multifocal and Invasive Gliomas. J Natl Cancer Inst, November 1, 2006; 98(21): 1546 - 1557. [Abstract] [Full Text] [PDF]

				C.-M. Park, M.-J. Park, H.-J. Kwak, H.-C. Lee, M.-S. Kim, S.-H. Lee, I.-C. Park, C. H. Rhee, and S.-I. Hong Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8511 - 8519. [Abstract] [Full Text] [PDF]

				E. Goebell, J. Fiehler, X.-Q. Ding, S. Paustenbach, S. Nietz, O. Heese, T. Kucinski, C. Hagel, M. Westphal, and H. Zeumer Disarrangement of Fiber Tracts and Decline of Neuronal Density Correlate in Glioma Patients--A Combined Diffusion Tensor Imaging and 1H-MR Spectroscopy Study AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1426 - 1431. [Abstract] [Full Text] [PDF]

				M. D. Jenkinson, D. G. du Plessis, T. S. Smith, K. A. Joyce, P. C. Warnke, and C. Walker Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features Brain, July 1, 2006; 129(7): 1884 - 1891. [Abstract] [Full Text] [PDF]

				T. Rosenzweig, A. Ziv-Av, C. Xiang, W. Lu, S. Cazacu, D. Taler, C. G. Miller, R. Reich, Y. Shoshan, Y. Anikster, et al. Related to Testes-Specific, Vespid, and Pathogenesis Protein-1 (RTVP-1) Is Overexpressed in Gliomas and Regulates the Growth, Survival, and Invasion of Glioma Cells. Cancer Res., April 15, 2006; 66(8): 4139 - 4148. [Abstract] [Full Text] [PDF]

				B. A. Cohen, E. A. Knopp, H. Rusinek, J. S. Babb, D. Zagzag, and O. Gonen Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2170 - 2177. [Abstract] [Full Text] [PDF]

				M. Nakada, J. A. Niska, N. L. Tran, W. S. McDonough, and M. E. Berens EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion Am. J. Pathol., August 1, 2005; 167(2): 565 - 576. [Abstract] [Full Text] [PDF]

				J. N. Rich, C. Hans, B. Jones, E. S. Iversen, R. E. McLendon, B.K. A. Rasheed, A. Dobra, H. K. Dressman, D. D. Bigner, J. R. Nevins, et al. Gene Expression Profiling and Genetic Markers in Glioblastoma Survival Cancer Res., May 15, 2005; 65(10): 4051 - 4058. [Abstract] [Full Text] [PDF]

				N.-M. Tsai, S.-Z. Lin, C.-C. Lee, S.-P. Chen, H.-C. Su, W.-L. Chang, and H.-J. Harn The Antitumor Effects of Angelica sinensis on Malignant Brain Tumors In vitro and In vivo Clin. Cancer Res., May 1, 2005; 11(9): 3475 - 3484. [Abstract] [Full Text] [PDF]

				F. Lefranc, J. Brotchi, and R. Kiss Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis J. Clin. Oncol., April 1, 2005; 23(10): 2411 - 2422. [Abstract] [Full Text] [PDF]

				Q. Shi, S. Bao, J. A. Maxwell, E. D. Reese, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation J. Biol. Chem., December 10, 2004; 279(50): 52200 - 52209. [Abstract] [Full Text] [PDF]

				Y.-y. Chuang, N. L. Tran, N. Rusk, M. Nakada, M. E. Berens, and M. Symons Role of Synaptojanin 2 in Glioma Cell Migration and Invasion Cancer Res., November 15, 2004; 64(22): 8271 - 8275. [Abstract] [Full Text] [PDF]

				A. Angers-Loustau, R. Hering, T. E. Werbowetski, D. R. Kaplan, and R. F. Del Maestro Src Regulates Actin Dynamics and Invasion of Malignant Glial Cells in Three Dimensions Mol. Cancer Res., November 1, 2004; 2(11): 595 - 605. [Abstract] [Full Text] [PDF]

				M. C. Chamberlain Gliomatosis cerebri: Better definition, better treatment Neurology, July 27, 2004; 63(2): 204 - 205. [Full Text] [PDF]

				M. D. Hjelmeland, A. B. Hjelmeland, S. Sathornsumetee, E. D. Reese, M. H. Herbstreith, N. J. Laping, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich SB-431542, a small molecule transforming growth factor-{beta}-receptor antagonist, inhibits human glioma cell line proliferation and motility Mol. Cancer Ther., June 1, 2004; 3(6): 737 - 745. [Abstract] [Full Text] [PDF]

				W. Fischer, L. Gustafsson, A.-K. Mossberg, J. Gronli, S. Mork, R. Bjerkvig, and C. Svanborg Human {alpha}-Lactalbumin Made Lethal to Tumor Cells (HAMLET) Kills Human Glioblastoma Cells in Brain Xenografts by an Apoptosis-Like Mechanism and Prolongs Survival Cancer Res., March 15, 2004; 64(6): 2105 - 2112. [Abstract] [Full Text] [PDF]

				N Nathoo, G H Barnett, and M Golubic The eicosanoid cascade: possible role in gliomas and meningiomas J. Clin. Pathol., January 1, 2004; 57(1): 6 - 13. [Abstract] [Full Text] [PDF]